Is It Too Late to Buy Vaxart Stock?
You'd no doubt be quite pleased if some of the stocks in your investment portfolio had doubled year to date. A return of 100% or more in half a year would certainly be something to smile about.
But what if you owned a stock that delivered a gain of almost 2,000% in the last six months? That's the kind of performance that would warrant much more than just a smile. Perhaps cartwheels would be in order.
There's at least one stock that has actually generated such a sizzling year-to-date return: Vaxart (NASDAQ: VXRT). But is it too late to buy this high-flying biotech stock?
Source Fool.com
